SHINE Medical Technologies, LLC; Medical Isotope Production Facility
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Nuclear Regulatory Commission (NRC) has issued Supplement 1 to NUREG-2183, "Environmental Impact Statement Supplement Related to the Operating License for the SHINE Medical Isotope Production Facility." NUREG-2183 was issued October 2015. SHINE Medical Technologies, LLC (SHINE) is requesting a license to operate the Medical Isotope Production Facility (SHINE facility) in Janesville, Wisconsin.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.